176 related articles for article (PubMed ID: 33307221)
1. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis.
Zheng M; Wu C; Yang K; Yang Y; Liu Y; Gao S; Wang Q; Li C; Chen L; Li H
Pharmacol Res; 2021 Feb; 164():105367. PubMed ID: 33307221
[TBL] [Abstract][Full Text] [Related]
2. Hexokinase 2 Inhibition and Biological Effects of BNBZ and Its Derivatives: The Influence of the Number and Arrangement of Hydroxyl Groups.
Juszczak K; Kubicka A; Kitel R; Dzido G; Łabieniec-Watała M; Zawadzki S; Marczak A; Walczak K; Matczak K; Tomczyk MD
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269760
[TBL] [Abstract][Full Text] [Related]
3. Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2.
Li W; Zheng M; Wu S; Gao S; Yang M; Li Z; Min Q; Sun W; Chen L; Xiang G; Li H
J Exp Clin Cancer Res; 2017 Apr; 36(1):58. PubMed ID: 28427443
[TBL] [Abstract][Full Text] [Related]
4. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
Zou J; Wang Y; Liu M; Huang X; Zheng W; Gao Q; Wang H
Cell Biochem Funct; 2018 Aug; 36(6):303-311. PubMed ID: 29984416
[TBL] [Abstract][Full Text] [Related]
5. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.
Xu S; Herschman HR
Cancer Res; 2019 Dec; 79(23):5907-5914. PubMed ID: 31434645
[TBL] [Abstract][Full Text] [Related]
6. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
8. Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.
Liu Y; Murray-Stewart T; Casero RA; Kagiampakis I; Jin L; Zhang J; Wang H; Che Q; Tong H; Ke J; Jiang F; Wang F; Wan X
Int J Oncol; 2017 Jun; 50(6):2011-2023. PubMed ID: 28498475
[TBL] [Abstract][Full Text] [Related]
9. Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics.
Garcia SN; Guedes RC; Marques MM
Curr Med Chem; 2019; 26(41):7285-7322. PubMed ID: 30543165
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism.
Zhang M; Liu Q; Zhang M; Cao C; Liu X; Zhang M; Li G; Xu C; Zhang X
J Nanobiotechnology; 2020 Nov; 18(1):161. PubMed ID: 33160373
[TBL] [Abstract][Full Text] [Related]
11. Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer.
Fan K; Fan Z; Cheng H; Huang Q; Yang C; Jin K; Luo G; Yu X; Liu C
Cancer Med; 2019 Oct; 8(13):5903-5915. PubMed ID: 31426130
[TBL] [Abstract][Full Text] [Related]
12. Linker residues regulate the activity and stability of hexokinase 2, a promising anticancer target.
Ferreira JC; Khrbtli AR; Shetler CL; Mansoor S; Ali L; Sensoy O; Rabeh WM
J Biol Chem; 2021; 296():100071. PubMed ID: 33187984
[TBL] [Abstract][Full Text] [Related]
13. MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
Liu Y; Huo Y; Wang D; Tai Y; Li J; Pang D; Zhang Y; Zhao W; Du N; Huang Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):885-892. PubMed ID: 29763606
[TBL] [Abstract][Full Text] [Related]
14. Lectin PCL inhibits the Warburg effect of PC3 cells by combining with EGFR and inhibiting HK2.
Zhang H; Du X; Sun TT; Wang CL; Li Y; Wu SZ
Oncol Rep; 2017 Mar; 37(3):1765-1771. PubMed ID: 28098871
[TBL] [Abstract][Full Text] [Related]
15. The development of small-molecule inhibitors targeting hexokinase 2.
Shan W; Zhou Y; Tam KY
Drug Discov Today; 2022 Sep; 27(9):2574-2585. PubMed ID: 35609742
[TBL] [Abstract][Full Text] [Related]
16. Degradation of Hexokinase 2 Blocks Glycolysis and Induces GSDME-Dependent Pyroptosis to Amplify Immunogenic Cell Death for Breast Cancer Therapy.
Sang R; Fan R; Deng A; Gou J; Lin R; Zhao T; Hai Y; Song J; Liu Y; Qi B; Du G; Cheng M; Wei G
J Med Chem; 2023 Jul; 66(13):8464-8483. PubMed ID: 37376788
[TBL] [Abstract][Full Text] [Related]
17. Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cells.
Kim DJ; Vo MT; Choi SH; Lee JH; Jeong SY; Hong CH; Kim JS; Lee UH; Chung HM; Lee BJ; Cho WJ; Park JW
Mol Biol Cell; 2019 Mar; 30(5):542-553. PubMed ID: 30650008
[TBL] [Abstract][Full Text] [Related]
18. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
Molecules; 2019 May; 24(10):. PubMed ID: 31137633
[TBL] [Abstract][Full Text] [Related]
19. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
20. miR‑185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2.
Liu C; Cai L; Li H
Mol Med Rep; 2019 Sep; 20(3):2774-2782. PubMed ID: 31524259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
